Charles Schwab Investment Management Inc Axonics, Inc. Transaction History

Charles Schwab Investment Management Inc

$519 Billion
Q2 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Axonics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 413,870 shares of AXNX stock, worth $28.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

413,870

Previous 400,677 3.29%

Holding current value

$28.7 Million

Previous $27.6 Million 0.69%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$66.47 - $69.65 $876,938 - $918,892	13,193 Added 3.29%	413,870 $27.8 Million
Q1 2024 May 08, 2024	SELL	$56.67 - $69.36 $145,981 - $178,671	-2,576 Reduced 0.64%	400,677 $27.6 Million
Q4 2023 Feb 06, 2024	BUY	$49.38 - $63.75 $414,051 - $534,543	8,385 Added 2.12%	403,253 $25.1 Million
Q3 2023 Nov 08, 2023	BUY	$48.64 - $62.51 $625,704 - $804,128	12,864 Added 3.37%	394,868 $22.2 Million
Q2 2023 Aug 09, 2023	SELL	$47.99 - $60.21 $318,941 - $400,155	-6,646 Reduced 1.71%	382,004 $19.3 Million
Q1 2023 May 11, 2023	BUY	$52.6 - $67.34 $156,169 - $199,932	2,969 Added 0.77%	388,650 $21.2 Million
Q4 2022 Feb 13, 2023	BUY	$59.56 - $76.6 $540,090 - $694,608	9,068 Added 2.41%	385,681 $24.1 Million
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $2.5 Million - $3.37 Million	43,082 Added 12.92%	376,613 $26.5 Million
Q2 2022 Aug 15, 2022	SELL	$39.5 - $64.42 $74,931 - $122,204	-1,897 Reduced 0.57%	333,531 $18.9 Million
Q1 2022 May 13, 2022	BUY	$43.74 - $62.76 $376,601 - $540,363	8,610 Added 2.63%	335,428 $21 Million
Q4 2021 Feb 11, 2022	BUY	$50.01 - $73.35 $296,059 - $434,231	5,920 Added 1.84%	326,818 $18.3 Million
Q3 2021 Nov 16, 2021	BUY	$59.21 - $78.66 $3.99 Million - $5.3 Million	67,405 Added 26.59%	320,898 $20.9 Million
Q2 2021 Aug 16, 2021	BUY	$51.39 - $66.9 $2.34 Million - $3.05 Million	45,553 Added 21.91%	253,493 $16.1 Million
Q1 2021 May 17, 2021	BUY	$49.14 - $59.89 $592,186 - $721,734	12,051 Added 6.15%	207,940 $12.5 Million
Q4 2020 Feb 16, 2021	BUY	$42.19 - $51.5 $134,079 - $163,667	3,178 Added 1.65%	195,889 $9.78 Million
Q3 2020 Nov 13, 2020	BUY	$35.33 - $51.04 $1.26 Million - $1.82 Million	35,734 Added 22.76%	192,711 $9.84 Million
Q2 2020 Aug 14, 2020	BUY	$22.91 - $39.83 $1.23 Million - $2.14 Million	53,684 Added 51.97%	156,977 $5.51 Million
Q1 2020 May 15, 2020	BUY	$16.44 - $37.73 $135,005 - $309,838	8,212 Added 8.64%	103,293 $2.63 Million
Q4 2019 Feb 07, 2020	BUY	$19.57 - $28.96 $498,839 - $738,190	25,490 Added 36.63%	95,081 $2.64 Million
Q3 2019 Nov 08, 2019	BUY	$26.92 - $42.41 $168,573 - $265,571	6,262 Added 9.89%	69,591 $1.87 Million
Q2 2019 Aug 09, 2019	BUY	$18.54 - $40.97 $353,891 - $782,035	19,088 Added 43.15%	63,329 $2.6 Million
Q1 2019 May 14, 2019	SELL	$13.32 - $24.35 $18,621 - $34,041	-1,398 Reduced 3.06%	44,241 $1.06 Million
Q4 2018 Feb 14, 2019	BUY	$13.2 - $16.43 $602,434 - $749,848	45,639 New	45,639 $690,000

Others Institutions Holding AXNX

# of Institutions

241

Shares Held

42.8M

Call Options Held

73.7K

Put Options Held

230K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.41B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Axonics, Inc. Transaction History